Chemoinformaics analysis of 3-(2,4,5-TRIMETHOXYPHENYL)PROP-2-ENAL
Molecular Weight | 222.24 | nRot | 5 |
Heavy Atom Molecular Weight | 208.128 | nRig | 8 |
Exact Molecular Weight | 222.089 | nRing | 1 |
Solubility: LogS | -2.461 | nHRing | 0 |
Solubility: LogP | 1.9 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 32.5831 |
nHD | 0 | BPOL | 20.1209 |
QED | 0.564 |
Synth | 2.166 |
Natural Product Likeliness | 0.632 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.005 |
Pgp-sub | 0.012 |
HIA | 0.009 |
CACO-2 | -4.601 |
MDCK | 0.0000144 |
BBB | 0.984 |
PPB | 0.785009 |
VDSS | 1.106 |
FU | 0.155444 |
CYP1A2-inh | 0.885 |
CYP1A2-sub | 0.945 |
CYP2c19-inh | 0.196 |
CYP2c19-sub | 0.917 |
CYP2c9-inh | 0.026 |
CYP2c9-sub | 0.836 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.924 |
CYP3a4-inh | 0.022 |
CYP3a4-sub | 0.434 |
CL | 8.11 |
T12 | 0.834 |
hERG | 0.026 |
Ames | 0.566 |
ROA | 0.941 |
SkinSen | 0.94 |
Carcinogencity | 0.823 |
EI | 0.837 |
Respiratory | 0.963 |
NR-Aromatase | 0.624 |
Antiviral | No |
Prediction | 0.61833 |